Tyrosine Kinase Inhibitor (TKI) Combination Scheduling Impacts Secondary FLT3 Tyrosine Kinase Domain (TKD) Mutation Profiles in a Xenograft Model of FLT3-ITD+ Acute Myeloid Leukemia (AML)
- Resource Type
- Abstract
- Source
- In
Blood 6 December 2014 124(21):3620-3620 - Subject
- Language
- ISSN
- 0006-4971